Folic acid fortification: Neural tube defect risk reduction-a global perspective

Folate in Health and Disease, Second Edition

Volumn , Issue , 2009, Pages 179-204

  Berry, Robert J ^a   Mulinare, Joseph ^a   Hamner, Heather C ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884836751     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (107)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-37.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. NEngl JMed 1992; 327:1832-35.
3. Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects—1983-1991. MMWR Morb Mortal Wkly Rep 1991; 40:513-16.
4. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992; 41:1-7.
5. Institute of Medicine. Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 1998:196-305.
6. Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid, Final rule. 21 CFR Parts 136, 137, and 139. Fed Reg 1996:8781-97.
7. Chen LT, Rivera MA. The Costa Rican experience: Reduction of neural tube defects following food fortification programs. NutrRev 2004; 62:S40-43.
8. Hertrampf E, Cortes F. Folic acid fortification of wheat flour: Chile. Nutr Rev 2004; 62:S44-48; discussion S49.
9. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, et al.Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med2007; 357:135-42.
10. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002; 66:33-39.
11. Centers for Disease Control and Prevention. Trends in wheat-flour fortification with folic acid and iron—Worldwide, 2004 and 2007. MMWR Morb Mortal Wkly Rep 2008; 57:8-10.
12. Hibbard BM, Hibbard ED, Jeffcoate TN. Folic acid and reproduction. Acta Obstet Gynecol Scand 1965; 44:375-400.
13. Smithells RW, Sheppard S. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980; 1:647.
14. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981; 56:911-18.
15. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ, Wild J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983; 1:1027-31.
16. Laurence KM, Campbell H. Trial of folate treatment to prevent recurrence of neural tube defect. Br Med J (Clin Res Ed) 1981; 282:2131.
17. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262:2847-52.
18. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988; 260:3141-45.
19. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn1990; 10:149-52.
20. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Med J Aust 1989; 150:613-19.
21. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993; 269:1257-61.
22. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995; 6:219-26.
23. Health Canada. Folic acid: The vitamin that helps protect against neural tube (birth) defects. Issues April 1993.
24. SOGC Genetics Committee. Recommendation on the use of folic acid for the prevention of neural tube defects. J Soc Obstet Gynaecol Can Supp 1993; 15:41-46.
25. PHAC. Folic Acid and Prevention of Neural Tube Defects: Information Update from PHAC—2008. Available at http://www.phac-aspc.gc.ca/fa-af/fa-af08-eng.php; accessed June 18, 2008.
26. Pan American Health Organization. Regional Meeting Report—Flour Fortification with Iron, Folic Acid, and Vitamin B12, Santiago, Chile [Report] 2003. Available at http://www.paho.org/English/AD/FCH/NU/ChileRglReport_2004.pdf; accessed Nov 6, 2008.
27. Food Standards Australia New Zealand (FSANZ). Final Assessment Report Proposal P295-Consideration for Mandatory Fortification with Folic Acid, 2006. Available at http://www.foodstandards.gov.au/_srcfiles/FAR_P295_Folic_Acid_Fortification_%20Att achs_1_6.pdf; accessed July 10, 2009.
28. SACN. Folate and Disease Prevention. Norwich, UK: The Stationary Office, 2006.
29. Food Safety Authority of Ireland. Report of the National Committee on Folic Acid Food Fortification. Available at http://www.fsai.ie/publications/reports/folic_acid.pdf; accessed August 21, 2008.
30. Health Council of the Netherlands. Towards an Optimal Use of Folic Acid. The Hague, the Netherlands: Health Council of the Netherlands, 2008: publication no. 2008/02E.
31. Darnton-Hill I, Webb P, Harvey PW, Hunt JM, Dalmiya N, Chopra M, Ball MJ, Bloem MW, de Benoist B. Micronutrient deficiencies and gender: Social and economic costs. Am J Clin Nutr 2005; 81:1198S-205S.
32. Mannar MG, Sankar R. Micronutrient fortification of foods—Rationale, application, and impact. Indian J Pediatr 2004; 71:997-1002.
33. Taucher SC. Services for the care and prevention of birth defects. Reduced report of a World Health Organization and March of Dimes Foundation meeting. Rev Med Chile2007; 135:806-13.
34. Mertz W. Food fortification in the United States. Nutr Rev 1997; 55:44-49.
35. Hannon-Fletcher MP, Armstrong NC, Scott JM, Pentieva K, Bradbury I, Ward M, Strain JJ, et al. Determining bioavailability of food folates in a controlled intervention study. Am J Clin Nutr 2004; 80:911-18.
36. Richardson DP. Food fortification. Proc Nutr Soc 1990; 49:39-50.
37. Flour Fortification Initiative. Flour Fortification Initiative Home Page. Available at www.sph.emory.edu/wheatflour; accessed August 21, 2008.
38. Dary O. Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12. Food Nutr Bull 2008; 29:S214-24.
39. Flour Fortification Initiative. Summary Report—Second Technical Workshop on Wheat Flour Fortification: Practical Recommendations for National Application, Stone Mountain, Georgia, USA. Available at http://www.sph.emory.edu/wheatflour/atlanta08/Atlanta_Summary_Report_Oct%207.pdf; accessed October 17, 2008.
40. Llanos A, Hertrampf E, Cortes F, Pardo A, Grosse SD, Uauy R. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 2007; 83:295-303.
41. Hertrampf E, Cortes F. National food-fortification program with folic acid in Chile. Food Nutr Bull 2008; 29:S231-37.
42. Flour Fortification Initiative. Report of the Workshop of Wheat Flour Fortification: Cuernavaca, Mexico. Available at http://www.sph.emory.edu/wheatflour/CKPAFF/index.htm; accessed August 21, 2008.
43. Grosse SD, Waitzman NJ, Romano PS, Mulinare J. Reevaluating the benefits of folic acid fortification in the United States: Economic analysis, regulation, and public health. Am J Public Health 2005; 95:1917-22.
44. World Health Organization. Food and Agriculture Organization. Guidelines on Food Fortification with Micronutrients. Geneva World Health Organization and Food and Agriculture Organization of the United Nations, 2006.
45. Food and Drug Administration. Food labeling: Health claims and label statement; folate and neural tube defects. Fed Reg 1993:53254-95.
46. Lewis CJ, Crane NT, Wilson DB, Yetley EA. Estimated folate intakes: Data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr 1999; 70:198-207.
47. Yetley EA, Rader JI. Modeling the level of fortification and post-fortification assessments: U.S. experience. Nutr Rev 2004; 62:S50-59; discussion S60-61.
48. Boushey CJ, Edmonds JW, Welshimer KJ. Estimates of the effects of folic-acid fortification and folic-acid bioavailability for women. Nutrition 2001; 17:873-79.
49. Caudill MA, Le T, Moonie SA, Esfahani ST, Cogger EA. Folate status in women of childbearing age residing in Southern California after folic acid fortification. J Am Coll Nutr 2001; 20:129-34.
50. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002; 132:2792-98.
51. Quinlivan EP, Gregory JF 3rd. Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr 2003; 77:221-25.
52. Quinlivan EP, Gregory JF 3rd. Reassessing folic acid consumption patterns in the United States (1999-2004): Potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 2007; 86:1773-79.
53. Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: Findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 2007; 85:1409-16.
54. Rader JI, Weaver CM, Angyal G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem 2000; 70:275-89.
55. Canada Gazette. Food and drugs regulations. SOR/96-527. Canada Gazette Part II 1996. Available at http://canadagazette.gc.ca/partII/1998/19981125/html/sor550-e.html; accessed September 27, 2008.
56. De Wals P, Rusen ID, Lee NS, Morin P, Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res A Clin Mol Teratol 2003; 67:919-23.
57. Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 2008; 82:211-16.
58. Berner LA, Clydesdale FM, Douglass JS. Fortification contributed greatly to vitamin and mineral intakes in the United States, 1989-1991. J Nutr 2001; 131:2177-83.
59. Imhoff-Kunsch B, Flores R, Dary O, Martorell R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr 2007; 137:1017-22.
60. Oakley GP Jr, Weber MB, Bell KN, Colditz P. Scientific evidence supporting folic acid fortification of flour in Australia and New Zealand. Birth Defects Res A Clin Mol Teratol2004; 70:838-41.
61. Busby A, Abramsky L, Dolk H, Armstrong B. Preventing neural tube defects in Europe: Population based study. BMJ 2005; 330:574-75.
62. Fletcher RJ, Bell IP, Lambert JP. Public health aspects of food fortification: A question of balance. Proc Nutr Soc 2004; 63:605-14.
63. Castilla EE, Orioli IM, Lopez-Camelo JS, Dutra Mda G, Nazer-Herrera J. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet A 2003; 123A:123-28.
64. Hertrampf E, Cortes F, Erickson JD, Cayazzo M, Freire W, Bailey LB, Howson C, Kauwell GP, Pfeiffer C. Consumption of folic acid-fortified bread improves folate status in women of reproductive age in Chile. J Nutr 2003; 133:3166-69.
65. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285:2981-86.
66. Lopez-Camelo JS, Orioli IM, da Graca Dutra M, Nazer-Herrera J, Rivera N, Ojeda ME, Canessa A, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet A 2005; 135:120-25.
67. Mathews TJ. Trends in Spina Bifida and Anencephalus in the United States, 1991-2005. NCHS Health E-stats 2007. Available at http://www.cdc.gov/nchs/products/pubs/pubd/hestats/spine_anen.htm; accessed May 2, 2008.
68. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002; 167:241-45.
69. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002; 360:2047-48.
70. Hickling S, Hung J, Knuiman M, Jamrozik K, McQuillan B, Beilby J, Thompson P. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: A population based cohort study. J Epidemiol Community Health 2005; 59:371-76.
71. Hoey L, McNulty H, Askin N, Dunne A, Ward M, Pentieva K, Strain J, Molloy AM, Flynn CA, Scott JM. Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 2007; 86:1405-13.
72. Bower C, Ryan A, Rudy E, Miller M. Trends in neural tube defects in Western Australia. Aust N Z J Public Health 2002; 346:725-30.
73. Chan A, Pickering J, Haan E, Netting M, Burford A, Johnson A, Keane RJ. “Folate before pregnancy”: The impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust 2001; 174:631-36.
74. Halliday JL, Riley M. Fortification of foods with folic acid. N Engl J Med 2000; 343:970-71; author reply 2.
75. Oddy WH, Miller M, Payne JM, Serna P, Bower CI. Awareness and consumption of folate-fortified foods by women of childbearing age in Western Australia. Public Health Nutr 2007; 10:989-95.
76. Boulet SL, Yang Q, Mai C, Kirby RS, Collins JS, Robbins JM, Meyer R, Canfield MA, Mulinare J. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol 2008; 82:527-32.
77. Liu S, West R, Randell E, Longerich L, O’Connor KS, Scott H, Crowley M, Lam A, Prabhakaran V, McCourt C. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth 2004; 4:20.
78. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001; 358:2069-73.
79. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995; 274:1698-702.
80. Senti FR, Pilch SM. Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II). J Nutr 1985; 115:1398-402.
81. Dietrich M, Brown CJ, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 2005; 24:266-74.
82. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, Fisher KD, Mulinare J, Osterloh JD. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 2007; 86:718-27.
83. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med1999; 340:1449-54.
84. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999; 354:915-16.
85. Centers for Disease Control and Prevention. Folate status in women of childbearing age, by race/ethnicity—United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2002; 51:808-10.
86. Ray JG, Vermeulen MJ, Boss SC, Cole DE. Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology2002; 13:238-40.
87. Watkins ML, Edmonds L, McClearn A, Mullins L, Mulinare J, Khoury M. The surveillance of birth defects: The usefulness of the revised US standard birth certificate. Am J Public Health 1996; 86:731-34.
88. Cragan JD, Roberts HE, Edmonds LD, Khoury MJ, Kirby RS, Shaw GM, Velie EM, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis—United States, 1985-1994. MMWR CDC Surveill Summ 1995; 44:1-13.
89. Centers for Disease Control and Prevention. Folate status in women of childbearing age, by race/ethnicity—United States, 1999-2000, 2001-2002, and 2003-2004. MMWR Morb Mortal Wkly Rep 2007; 55:1377-80.
90. Ganji V, Kafai MR. Trends in serum folate, RBC folate, and circulating total homocysteine concentrations in the United States: Analysis of data from National Health and Nutrition Examination Surveys, 1988-1994, 1999-2000, and 2001-2002. J Nutr 2006; 136:153-58.
91. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics2005; 116:580-86.
92. Dowd JB, Aiello AE. Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US? Int J Epidemiol 2008; 37:1059-66.
93. Centers for Disease Control and Prevention. Use of dietary supplements containing folic acid among women of childbearing age—US, 2005. MMWR Morb Mortal Wkly Rep2005; 54:955-58.
94. Green-Raleigh K, Carter H, Mulinare J, Prue C, Petrini J. Trends in folic acid awareness and behavior in the United States: The Gallup Organization for the March of Dimes Foundation surveys, 1995-2005. Matern Child Health J 2006; 10:S177-82.
95. Morin P, De Wals P, Noiseux M, Niyonsenga T, St-Cyr-Tribble D, Tremblay C. Pregnancy planning and folic acid supplement use: Results from a survey in Quebec. Prev Med 2002; 35:143-49.
96. Morin P, De Wals P, St-Cyr-Tribble D, Niyonsenga T, Payette H. Pregnancy planning: A determinant of folic acid supplements use for the primary prevention of neural tube defects. Can J Public Health 2002; 93:259-63.
97. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 1996; 347:657-59.
98. Berry RJ, Li Z. Folic acid alone prevents neural tube defects: Evidence from the China study. Epidemiology 2002; 13:114-16.
99. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341:1485-90.
100. Berry R, Carter H, Yang Q. Cognitive impairment in older Americans in the age of folic acid fortification. Letter. Am J Clin Nutr 2007; 86:265-67.
101. Yeung L, Yang Q, Berry RJ. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA 2008; 300:2486-87.
102. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, Botting B, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: Are the recommendations working? BMJ 2005; 330:571-73.
103. Oakley GP Jr, Bell KN, Weber MB. Recommendations for accelerating global action to prevent folic acid-preventable birth defects and other folate-deficiency diseases: Meeting of experts on preventing folic acid-preventable neural tube defects. Birth Defects Res A Clin Mol Teratol 2004; 70:835-37.
104. World Health Organization. Folate and Vitamin B12 Deficiencies: Proceedings of a WHO Technical Consultation, October 18-21, 2005. Boston: World Health Organization of the United Nations, 2008. Food Nutr Bull 2008 Jun; 29:no.2 (supplement)
105. Christianson A, Modell B, Howson C. March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. White Plains, NY, 2006.
106. Bell KN, Oakley GP Jr. Tracking the prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol. 2006; 76:654-57.
107. Rosenberg IH. Science-based micronutrient fortification: Which nutrients, how much, and how to know? Am J Clin Nutr 2005; 82:279-80.